Literature DB >> 26499420

Migrant health: the Apulian model.

Cinzia Germinario1, Maria Serena Gallone2, Silvio Tafuri2.   

Abstract

INTRODUCTION: Since the 1990s Puglia has been totally involved in the reception and assistance of refugees. The prevention of infectious diseases among migrants, especially those residing in communities, is an important concern for public health authorities, since infectious diseases eliminated in Europe may still be widespread in the migrants' countries of origin, and other diseases may have a higher incidence than in European countries. Thus immigrants may contribute to the burden and spread of infectious diseases.
OBJECTIVE: We describe the Apulian model of management and prevention of infectious disease among the population of Asylum Seeker Centres (CARA). It consists of a number of activities: surveillance of Poliovirus circulation, tuberculosis screening, seroprevalence studies of viral hepatitis and HIV, an immunization program for children, and syndromic surveillance. All the activities are organized and carried out by the Regional Observatory for Epidemiology among refugees hosted in the Bari Palese CARA.
RESULTS: Surveillance of Poliovirus circulation has been carried out periodically since 2008 by assessing the presence of wild poliovirus or Sabin-like poliovirus in stool samples and seroprevalence studies. Data did not show circulation of poliovirus and indicated a good level of immunization against polio among refugees. Seroprevalence studies of viral hepatitis and HIV were carried out in 2008 and involved 529 refugees; 44 individuals (8.3%) were HBsAg positive, 24 (4.5%) were anti-HCV positive, 8 (1.5%) were HIV positive. Tuberculosis screening started in 2009 after a refugee's death due to tuberculosis and has been ongoing since then. The Mantoux tuberculin skin test is used and cutipositive migrants are examined by chest X-ray. Around 50% of migrants have been found to be cutipositive and 10% showed TB sequelae. Syndromic surveillance and an immunization program began in 2011 because of the significant increase in migration flow following civil unrest in North Africa; respiratory tract infection and diarrhoea were the most frequent notified syndromes. The immunization program involved 129 children coming from 23 countries: all received the appropriate vaccinations. The program also includes an annual special session to vaccinate all refugees against flu.
CONCLUSIONS: The results confirmed some traditional concerns about migrant health and especially about the control of infectious diseases among these populations and the need, from our point of view, to strengthen screening to aid the development of trust between migrants and resident population.

Entities:  

Mesh:

Year:  2015        PMID: 26499420

Source DB:  PubMed          Journal:  Epidemiol Prev        ISSN: 1120-9763            Impact factor:   1.901


  4 in total

1.  Long-Term Immunogenicity of Inactivated and Oral Polio Vaccines: An Italian Retrospective Cohort Study.

Authors:  Angela Maria Vittoria Larocca; Francesco Paolo Bianchi; Anna Bozzi; Silvio Tafuri; Pasquale Stefanizzi; Cinzia Annatea Germinario
Journal:  Vaccines (Basel)       Date:  2022-08-17

2.  Immunization Offer Targeting Migrants: Policies and Practices in Italy.

Authors:  Teresa Dalla Zuanna; Martina Del Manso; Cristina Giambi; Flavia Riccardo; Antonino Bella; Maria Grazia Caporali; Maria Grazia Dente; Silvia Declich
Journal:  Int J Environ Res Public Health       Date:  2018-05-12       Impact factor: 3.390

3.  Surveillance on speed: Being aware of infectious diseases in migrants mass accommodations - an easy and flexible toolkit for field application of syndromic surveillance, Germany, 2016 to 2017.

Authors:  Navina Sarma; Alexander Ullrich; Hendrik Wilking; Stéphane Ghozzi; Andreas K Lindner; Christoph Weber; Alexandra Holzer; Andreas Jansen; Klaus Stark; Sabine Vygen-Bonnet
Journal:  Euro Surveill       Date:  2018-10

Review 4.  Infectious disease surveillance for refugees at borders and in destination countries: a scoping review.

Authors:  Majd Saleh; Zeina Farah; Natasha Howard
Journal:  BMC Public Health       Date:  2022-02-04       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.